Literature DB >> 22778472

MRI for the detection of prostate cancer origin vertebral metastases in the preosteoblastic phase.

Swaroop Revannasiddaiah1, Madhup Rastogi, Pragyat Thakur, Manoj Kumar Gupta, Ashwani Sood, Chittranjan Sharma.   

Abstract

This report describes the case of a gentleman aged 59 years presenting with low-back pain, who had underwent radical prostatectomy for prostate cancer 8 years ago. On evaluation, a slightly elevated serum alkaline-phosphatase level prompted a search for bone metastases. Although x-ray radiography and a bone scan were apparently normal, an MRI scan revealed the presence of metastatic marrow infiltration in the lumbar vertebrae. The patient subsequently was initiated on therapy with androgen-deprivation therapy and bisphosphonates, and currently enjoys symptom-free and progression-free survival. The images in this paper intend to impress upon the limitations of bone scan and x-ray radiography with regard to the detection of vertebral marrow infiltration in the absence of cortical bone invasion. In addition, a brief review of the pathophysiology of vertebral metastases arising from prostate cancer is included.

Entities:  

Mesh:

Year:  2012        PMID: 22778472      PMCID: PMC4543210          DOI: 10.1136/bcr-2012-006265

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  23 in total

1.  Nuclear medicine in myeloma: the state of the science and emerging trends.

Authors:  Ashwani Sood; Swaroop Revannasiddaiah; Rakesh Kumar
Journal:  Hell J Nucl Med       Date:  2011 Jan-Apr       Impact factor: 1.102

Review 2.  The cellular basis of site-specific tumor metastasis.

Authors:  B R Zetter
Journal:  N Engl J Med       Date:  1990-03-01       Impact factor: 91.245

3.  Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system.

Authors:  M M Steinborn; A F Heuck; R Tiling; M Bruegel; L Gauger; M F Reiser
Journal:  J Comput Assist Tomogr       Date:  1999 Jan-Feb       Impact factor: 1.826

4.  Osteopontin: possible role in prostate cancer progression.

Authors:  G N Thalmann; R A Sikes; R E Devoll; J A Kiefer; R Markwalder; I Klima; C M Farach-Carson; U E Studer; L W Chung
Journal:  Clin Cancer Res       Date:  1999-08       Impact factor: 12.531

5.  Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur.

Authors:  D B Mach; S D Rogers; M C Sabino; N M Luger; M J Schwei; J D Pomonis; C P Keyser; D R Clohisy; D J Adams; P O'Leary; P W Mantyh
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

6.  MR imaging of bone marrow lesions: relative conspicuousness on T1-weighted, fat-suppressed T2-weighted, and STIR images.

Authors:  S A Mirowitz; P Apicella; W R Reinus; A M Hammerman
Journal:  AJR Am J Roentgenol       Date:  1994-01       Impact factor: 3.959

7.  Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial.

Authors:  Lee S Rosen; David Gordon; N Simon Tchekmedyian; Ronald Yanagihara; Vera Hirsh; Maciej Krzakowski; Marek Pawlicki; Paul De Souza; Ming Zheng; Gladys Urbanowitz; Dirk Reitsma; John Seaman
Journal:  Cancer       Date:  2004-06-15       Impact factor: 6.860

Review 8.  Biology and clinical management of prostate cancer bone metastasis.

Authors:  Xiang-cang Ye; Michel Choueiri; Shi-Ming Tu; Sue-Hwa Lin
Journal:  Front Biosci       Date:  2007-05-01

9.  Modern Detection of Prostate Cancer's Bone Metastasis: Is the Bone Scan Era Over?

Authors:  Bertrand Tombal; Frederic Lecouvet
Journal:  Adv Urol       Date:  2011-10-16

10.  CXCR4 expression in prostate cancer progenitor cells.

Authors:  Anna Dubrovska; Jimmy Elliott; Richard J Salamone; Gennady D Telegeev; Alexander E Stakhovsky; Ihor B Schepotin; Feng Yan; Yan Wang; Laure C Bouchez; Sumith A Kularatne; James Watson; Christopher Trussell; Venkateshwar A Reddy; Charles Y Cho; Peter G Schultz
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.